Phibro Animal Health Corporation (PAHC)

Currency in USD
29.18
-0.26(-0.88%)
Closed·
After Hours
30.18+1.00(+3.43%)
·
PAHC Scorecard
Full Analysis
Net income is expected to grow this year
PAHC is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
28.8829.80
52 wk Range
16.1631.80
Key Statistics
Prev. Close
29.44
Open
29.53
Day's Range
28.88-29.8
52 wk Range
16.16-31.8
Volume
199.5K
Average Volume (3m)
282.41K
1-Year Change
54.97%
Book Value / Share
6.57
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PAHC Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
26.00
Downside
-10.90%
Members' Sentiments
Bearish
Bullish
ProTips
3 analysts have revised their earnings downwards for the upcoming period
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Phibro Animal Health Corporation Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal’s health and performance, food safety, and animal welfare; and engages in development, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds to fortify the daily feed requirements of their livestock’s diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was founded in 1946 and is headquartered in Teaneck, New Jersey.

Employees
1940

Phibro Animal Health Corporation Earnings Call Summary for Q3/2025

  • Q3 2025 results: EPS $0.63 (+19% vs forecast), revenue $347.8M (+12.4% vs forecast), stock up 11.4% post-announcement
  • Revenue up 32% YoY, adjusted EBITDA up 85%, driven by Animal Health segment (+42%) and Zoetis MFA portfolio integration
  • FY2025 outlook: Net sales $1.26-1.29B (+24-27% YoY), adjusted EBITDA +59-66%, adjusted EPS $1.96-$2.09
  • Strong liquidity with 3.2 current ratio; minimal tariff impact in 2025, but 5-10% effect expected in 2026
  • CEO highlights strategic investments in procurement and supply chain resilience; CFO confident in strong income growth
Last Updated: 08/05/2025, 15:00
Read Full Transcript

Compare PAHC to Peers and Sector

Metrics to compare
PAHC
Peers
Sector
Relationship
P/E Ratio
37.2x8.8x−0.5x
PEG Ratio
0.270.030.00
Price/Book
4.4x1.7x2.6x
Price / LTM Sales
1.0x1.8x3.2x
Upside (Analyst Target)
−14.3%27.3%41.7%
Fair Value Upside
Unlock18.3%6.1%Unlock

Analyst Ratings

1 Buy
2 Hold
1 Sell
Ratings:
4 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 26.00
(-10.90% Downside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.78%
Dividend Yield
1.64%
Industry Median 2.81%
Annualised payout
0.48
Paid quarterly
5-Years Growth
-
Growth Streak

Earnings

Latest Release
May 07, 2025
EPS / Forecast
0.63 / 0.53
Revenue / Forecast
347.80M / 309.50M
EPS Revisions
Last 90 days

PAHC Income Statement

People Also Watch

101.22
CRDO
+0.05%
14.45
OSCR
+1.76%
28.39
CNC
+6.09%
54.335
ASTS
-9.53%

FAQ

What Stock Exchange Does Phibro Trade On?

Phibro is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Phibro?

The stock symbol for Phibro is "PAHC."

What Is the Phibro Market Cap?

As of today, Phibro market cap is 1.18B.

What Is Phibro's Earnings Per Share (TTM)?

The Phibro EPS (TTM) is 0.78.

When Is the Next Phibro Earnings Date?

Phibro will release its next earnings report on 26 Aug 2025.

From a Technical Analysis Perspective, Is PAHC a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Phibro Stock Split?

Phibro has split 0 times.

How Many Employees Does Phibro Have?

Phibro has 1940 employees.

What is the current trading status of Phibro (PAHC)?

As of 27 Jul 2025, Phibro (PAHC) is trading at a price of 29.18, with a previous close of 29.44. The stock has fluctuated within a day range of 28.88 to 29.80, while its 52-week range spans from 16.16 to 31.80.

What Is Phibro (PAHC) Price Target According to Analysts?

The average 12-month price target for Phibro is USD26, with a high estimate of USD35 and a low estimate of USD19. 1 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Neutral. The stock has an -10.90% Downside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.